Newsfeeds Archive - Page 66 of 167

3 minute read

X4 Pharmaceuticals Announces Phase 1b Data Showing ‘100% of study participants (n=25) achieved robust responses to oral mavorixafor

September 27, 7:52 AM

100% of study participants (n=25) achieved robust responses to oral mavorixafor 100% of neutropenic participants (n=14) achieved normalized neutrophil counts Robust responses achieved across all CN disorders

XFOR

1 minute read

BLADE India Signs Non-Binding Order For Up To 200 eVTOL Vehicles From Eve Air Mobility

By Bill Haddad

September 27, 7:35 AM

BLADE India signs a purchase order for up to 200 of Eve's eVTOL, initially underwriting 50,000 hours of flight time per year in the region Intra-city helicopter flights to begin in a major Indian city as

BLDE

4 minute read

Equillium Announces Interim Results From EQUALISE Study In With Lupus Nephritis; Says ‘5 of 6 (83%) subjects achieved complete or partial response and 4 of 6 (67%) subjects achieved > 80% reduction in urine protein creatinine ratio (UPCR) by week 28’

By Bill Haddad

September 27, 7:06 AM

Itolizumab demonstrates clinically meaningful response in highly proteinuric subjects: 5 of 6 (83%) subjects achieved complete or partial response and 4 of 6 (67%) subjects achieved > 80% reduction

1 minute read

United Natural Foods Q4 Adj. EPS $1.27, Inline, Sales $7.30B Miss $7.34B Estimate

By Bill Haddad

September 27, 7:02 AM

United Natural Foods (NYSE:UNFI) reported quarterly earnings of $1.27 per share which met the analyst consensus estimate. This is a 7.63 percent increase over earnings of $1.18 per share from the same period last year.

UNFI

1 minute read

Merck’s KEYTRUDA Receives Four New Approvals In Japan, Including In High-Risk Early-Stage Triple-Negative Breast Cancer

By Bill Haddad

September 27, 6:46 AM

Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced that KEYTRUDA, Merck's anti-PD-1 therapy, received four new approvals from Japan's Ministry of Health, Labor and Welfare

MRK

1 minute read

Welsbach Technology Metals Acquisition Corp. Announces Extension To Business Combination Deadline To Dec. 30, 2022

By Bill Haddad

September 27, 6:31 AM

New York, NY, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Welsbach Technology Metals Acquisition Corp. (the "Company"), a blank check company formed for the purpose of effecting a merger, share exchange, asset

WTMA

1 minute read

Federal Reserve

Fed’s Evans Says It Is Appropriate To Slow Pace Of Rate Hikes At Some Point

By Bill Haddad

September 27, 6:20 AM

-Reuters

SPY

1 minute read

‘Biogen Agrees to Pay $900 Million Over Alleged Improper Physician Payments’ -WSJ

By Bill Haddad

September 26, 7:45 PM

https://www.wsj.com/articles/biogen-agrees-to-pay-900-million-over-alleged-improper-physician-payments-11664231855?mod=latest_headlines

BIIB

3 minute read

INDIEV And Malacca Straits Acquisition Company Limited Announce Merger Agreement; Holders Of Outstanding INDIEV Shares To Receive Shares In Malacca Valued At $600M

By Bill Haddad

September 26, 4:35 PM

DEVELOPER OF INDI ONE ELECTRIC VEHICLE PLANS TO GO PUBLIC ON NASDAQ CAPITAL MARKET Los Angeles CA, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Indiev, Inc. ("INDIEV"), an electronic vehicle company specializing in

MLAC

3 minute read

News

Exicure, Inc. Announces Restructuring Including 66% Workforce Reduction And Exploration Of Divestiture Opportunities For Clinical-Stage Asset In Immuno-Oncology And Preclinical Candidates

By Bill Haddad

September 26, 4:02 PM

Upon satisfaction of certain closing conditions including approval by Exicure stockholders, existing investor CBI USA, Inc. will purchase an aggregate of 3,400,000 shares of common stock for an aggregate purchase price

XCUR